Hub ยท Peptide Quality & Verification
Types of peptide impurities in synthetic peptides
Synthetic peptide impurities fall into two broad groups. Peptide-related impurities contain parts of the intended sequence, such as deletion and truncated sequences or oxidation and deamidation products. Non-peptide impurities include process reagents, residual solvents and elemental impurities. A European Medicines Agency guideline separates them this way, and different tests look for different groups.
01Two groupsContents
Picture a batch of cakes from a bakery. Some come out with a corner missing. Some go stale on the shelf. Some carry a trace of the tray's oil. Each flaw has a different cause, and you would spot each one a different way. A peptide made in a laboratory has the same pattern: its flaws come in families, and no single check sees them all.
This page is part of the peptide quality and verification hub. It names the main families of impurity in a synthetic peptide and shows which kind of test looks for which. It is research reference material, for research use only. The peak-area limits of a purity figure are covered on the HPLC purity page, so this page does not repeat them.
Guidethe peptide quality and verification hubHow research peptides are tested and verified: purity methods, certificates of analysis, batch traceability, and what each document can and cannot tell you.
Guidethe HPLC purity page
Key facts
| Source | European Medicines Agency (EMA) Guideline on the Development and Manufacture of Synthetic Peptides, EMA/CHMP/CVMP/QWP/367182/2025, dated 4 December 2025 |
|---|---|
| Scope of that guideline | Synthetic peptides used in a medicinal product. It is not a rule for research products |
| Two broad groups | Peptide-related impurities and non-peptide impurities |
| Sequence-related examples | Deletion sequences, truncated sequences, insertion sequences and stereoisomers |
| Degradation examples | Oxidation, hydrolysis, deamidation and isomerisation, among other pathways |
| Non-peptide examples | Process reagents and by-products, residual solvents, elemental impurities and nitrosamines |
| Results shown for Form Laboratories products | None on this page |
| Use | Research reference material. Not for human or animal use |
What are the main types of peptide impurities?
The EMA guideline says impurities are often categorised as peptide-related or non-peptide. Peptide-related impurities contain structural elements of the synthetic peptide sequence. Non-peptide impurities include process reagents and their by-products, residual solvents, elemental impurities and nitrosamines. The guideline calls purity one of the most important critical quality attributes for synthetic peptides. It is dated 4 December 2025, came into effect on 1 June 2026 and applies to peptides used in medicinal products, so this page does not present it as a rule for research products.
The guideline names three sources of peptide-related impurities: the starting materials, formation during manufacture, and degradation during manufacture or storage. Some related substances can come from more than one of these at once.
What are degradation impurities such as oxidation and deamidation?
Degradation products are peptides changed after they were made. The guideline lists these pathways: oxidation, hydrolysis, isomerisation, deamidation, cyclic imide formation, diketopiperazine and pyroglutamic acid formation, beta-elimination, condensation, disulfide cleavage or exchange, and acetylation. It says their content may increase during storage. It also says the likely pathways should be discussed in light of the peptide's amino acid composition and sequence.
The guideline classes aggregates, dimers and oligomers as high molecular weight impurities, formed during synthesis or storage. That is a separate family again, with a separate test named later on this page.
What are non-peptide impurities such as residual solvents?
Non-peptide impurities are material in the sample that is not a form of the peptide. The guideline names process reagents, by-products, residual solvents, elemental impurities and nitrosamines. Solid-phase synthesis washes the resin with solvents, and the guideline says the purge of every reagent and solvent should be addressed. Its specification list also has separate lines for counter-ion identity and content, residual trifluoroacetic acid (TFA) and water content.
A counter-ion is a small charged particle that comes with the peptide. The guideline notes that the type of counter-ion can affect the peptide's biological and physicochemical properties, and that acetate is usually used, with trifluoroacetate or chloride also possible.
Do different tests look for different impurity types?
Yes. The guideline lists separate specification tests: purity, with total and individual impurities; high molecular weight impurities by size-exclusion chromatography (SEC-LC) or other techniques; assay or content; counter-ion content; water content; residual solvents; elemental impurities; bacterial endotoxins; and microbiological purity. It also says that if one method cannot separate all the peptide-related impurities, additional independent methods may be needed. One test result therefore does not cover every family.
A chromatographic purity figure reads peak area on one method. The HPLC purity page covers what that figure can and cannot show. The mass spectrometry page covers identity, and the endotoxin, sterility and purity page covers the microbiological tests.
GuideThe HPLC purity page
GuideThe mass spectrometry pageHow mass spectrometry confirms peptide identity: what a matching mass shows, how fragmentation reads the sequence, and why identical masses call for a second test.
Guidethe endotoxin, sterility and purity pageWhat an endotoxin test, a sterility test and a purity test each measure, and which of the three the 14 lab reports on file at Form Laboratories document.
Evidence limits
What does this page not show?
This page shows no impurity result for any Form Laboratories product. The EMA guideline covers synthetic peptides in medicinal products, human and veterinary. It does not set rules for research material, and this page does not claim that it does. It states no more than the guideline does. Form Laboratories supplies research material for research use only, not for human or animal use.
Ask any supplier which tests a batch has had. The answer belongs on a dated report that names the batch, the method and the test. A report that lists one test says nothing about the families that test does not look for.
Comparison
Each impurity family, an example from the EMA guideline and the kind of test the guideline lists for it. Taken from EMA/CHMP/CVMP/QWP/367182/2025, which covers medicinal products and is not a rule for research products.
| Family | Examples named | Test the guideline lists | Not covered by |
|---|---|---|---|
| Sequence-related | Deletion, truncated and insertion sequences, stereoisomers | Purity: total and individual impurities, with extra independent methods where needed | A single test that cannot separate every related impurity |
| Degradation products | Oxidation, deamidation, hydrolysis, isomerisation | Purity and stability studies | Anything the chosen method cannot separate |
| Aggregates | Dimers, trimers, oligomers, aggregates | High molecular weight impurities by SEC-LC or other techniques | A purity figure alone |
| Non-peptide material | Residual solvents, process reagents, elemental impurities, counter-ions | Residual solvents, elemental impurities, counter-ion content, water content | A chromatographic purity figure |
FAQ
What are the main types of peptide impurities?
The EMA guideline groups them as peptide-related impurities, which contain parts of the intended sequence, and non-peptide impurities, such as process reagents, residual solvents and elemental impurities. The guideline covers peptides in medicinal products.
What is a deletion or truncated sequence?
A deletion sequence is a peptide with one or several amino acids missing, through incomplete coupling or deprotection. A truncated sequence is an acetylated fragment left when unreacted sites are capped during solid-phase synthesis (EMA guideline, 2025).
What are oxidation and deamidation in peptides?
They are two of the degradation pathways the EMA guideline lists, with hydrolysis, isomerisation and others. The guideline says the content of degradation products may increase during storage.
Does one purity test find every impurity?
No. The EMA guideline lists separate tests for purity, high molecular weight impurities, content, counter-ions, water, residual solvents, elemental impurities, endotoxins and microbiological purity. It also says additional independent methods may be needed to separate all peptide-related impurities.
Does this page show impurity results for Form Laboratories products?
No. It describes impurity categories only and shows no result for any Form Laboratories product. Form Laboratories supplies research material for research use only, not for human or animal use.
More in this hub
GuidePeptide Quality & VerificationHow research peptides are tested and verified: purity methods, certificates of analysis, batch traceability, and what each document can and cannot tell you.
GuideWhich peptide company is the most trusted?What regulator letters, batch tests and business records can show about peptide companies. Learn why company size cannot settle trust.
GuideHow to read a certificate of analysis (COA)What a certificate of analysis shows: its fields, purpose and layout, how it differs from a safety data sheet, what purity and identity numbers prove, and where the paperwork stops.
GuideHow to check a peptide certificate of analysis is genuineA field-by-field checklist for a peptide certificate of analysis: match the batch, confirm the laboratory, read the test scope, and see what each check can and cannot show.
GuideHow to check an Australian peptide supplier is legitimateTen checks for an Australian research peptide supplier: business identity, contact details, batch documents, test scope, payment records, handling and regulatory warnings.
GuideWhat research grade actually meansResearch grade is a catalogue phrase, not a published standard. What named grades like ACS and USP are, and what For Research Use Only does not mean.
GuideWhat a batch or lot number lets a researcher verifyA batch or lot number identifies one production run. What that code lets a researcher check, what it ties together, and where its verifying power stops.
GuideCJC-1295 with DAC vs without DAC: what is the difference?CJC-1295 with DAC and without DAC are two different peptides. Side-by-side sequence, half-life literature and registry numbers, and what modified GRF(1-29) means.
GuideSelank vs Semax: are they the same peptide?Selank and Semax are two different seven-amino-acid peptides that share a Pro-Gly-Pro ending. A position-by-position sequence table, origins, what studies say about which is better, DSIP, and the limits of comparing studies.
GuideIs NAD+ a peptide?NAD+ is a coenzyme made of two nucleotides, not a peptide. What the PubChem, ChEBI and wwPDB records show about its structure.
GuideHow mass spectrometry confirms peptide identityHow mass spectrometry confirms peptide identity: what a matching mass shows, how fragmentation reads the sequence, and why identical masses call for a second test.
GuideHow HPLC purity is measured for peptides
GuideEndotoxin, sterility and purity: three different testsWhat an endotoxin test, a sterility test and a purity test each measure, and which of the three the 14 lab reports on file at Form Laboratories document.
GuideBioburden vs endotoxin testing: what each one measuresBioburden testing counts living microorganisms. Endotoxin testing looks for a bacterial cell-wall molecule. Why one cannot stand in for the other, with ISO 11737-1 and FDA guidance cited.
GuideNet peptide content: what it is and how it is measuredNet peptide content is the share of a freeze-dried peptide's mass that is the peptide itself. How amino acid analysis, nitrogen analysis and mass balance measure it, and why it differs from HPLC purity.
GuidePeptide TFA salt: what trifluoroacetate is and how it is measuredA peptide TFA salt carries trifluoroacetate as its counterion. Why synthetic peptides often have it, how it is measured on its own, and why an HPLC purity figure does not show the salt form.
GuideTB-500 vs thymosin beta-4: is TB-500 the same molecule?TB-500 and thymosin beta-4 are not the same molecule in the papers that define them: a full-length protein against a short acetylated fragment, compared side by side.
GuideWhat does a peptide cleavage predictor measure?What peptide cleavage predictors estimate from an amino acid sequence, what cut-site scores mean, and why a computer prediction needs separate lab evidence.
GuideWhat is peptide mass fingerprinting, and what can it identify?Peptide mass, mass-to-charge ratio and mass fingerprinting explained: what a database match can identify, why sequence matters, and what purity needs.
Citations
1 sourcesEuropean Medicines Agency Guideline on the Development and Manufacture of Synthetic Peptides (EMA/CHMP/CVMP/QWP/367182/2025). 4 December 2025.
https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-development-manufacture-synthetic-peptides_en.pdf
Continue
Research reference material: lab report shown where one is on fileMore on peptide quality & verificationForm Laboratories supplies research-use-only reference material. This article is an educational summary of published third-party literature. It is not medical advice, not a use instruction, and research material is not for human or animal use.
